Cannabinor.
Research-backed compound with potential health benefits. Marketed as a sleep aid. The theory is it has mild sedative properties, but solid human data is lacking. Some early research on appetite and inflammation.
Reviewed March 2026
- Category
- Compound
What Cannabinor is, and what it does.
- Does it work
- Suits people who follow early-stage compounds closely and read certificates of analysis. Human research is thin, so identity and content testing is the thing to look for.
- How much to take
- There's no standard dose. Companies sell anything from 5mg to 50mg. Most studies are old and inconclusive. Start low, around 5-10mg, and see how you feel.
- Time to feel it
- Nobody has published a controlled human onset time for it. Products aimed at evening use are taken about an hour before bed, which is a habit rather than a measured figure.
- The first dose
- You might feel a little drowsy an hour or so after taking it. Or you might feel absolutely nothing. Don't be surprised either way.
- With regular use
- Unknown. There are no long-term human studies on isolated CBN supplementation. We don't know the effects of taking it nightly for months or years.
- How well tolerated
- Seems well tolerated in the short term, but we lack long-term data. The biggest risk is product quality—unlisted THC is a real concern. Always demand a Certificate of Analysis (COA).
- How it feels
- A mild, gentle sense of relaxation for some. Not a powerful sedative. Think 'calm,' not 'knocked out.' Many report no noticeable effect.
- The overlooked benefit
- The naming trips people up. Cannabinor is a synthetic research compound and is not the plant molecule cannabinol, so it is worth checking which one a label actually names.
25 to 50mg a day is where Cannabinor works.
Source: Pharmos Corp Phase II trial data (discontinued); CB2 receptor agonist
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Cannabinor is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- cannabinoid receptor two activityIn vitro study
- discomfort signalling in animal modelsAnimal study
- sleep onset or sleep quality in peopleNarrative review
Questions people ask about Cannabinor.
- Will CBN get me high?
- It shouldn't. It's considered non-intoxicating. But low-quality products might contain enough THC to cause mild effects. Check the lab reports.
- Will I fail a drug test?
- Possibly. CBN is chemically similar to THC and some tests can't tell the difference. If you get drug tested for work, avoid it.
- Is it better than CBD for sleep?
- The evidence for CBD, while still developing, is stronger than for CBN. The idea that CBN is the ultimate sleep cannabinoid is mostly marketing right now.
- Can I take it with melatonin?
- Probably fine, but it's better to try one thing at a time. That way you know what's actually working (or not working).
- Is it addictive?
- Unlikely to be physically addictive. Like any sleep aid, it's possible to become psychologically dependent on it for sleep.
- What's the difference between CBN and CBD?
- They're two different compounds from the cannabis plant. CBD is well-studied for anxiety and inflammation. CBN is hyped for sleep but has much less research behind it.
No pairing data for Cannabinor yet.
Nothing on file for Cannabinor, either from a combination trial or from settled biochemistry. When either lands, it appears here with its source.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
21 pairings are live across the library today. Checked 9 August 2026.
Nothing specific on file for Cannabinor. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.